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Available online 13 December 2017Background: Trials using echocardiographic mechanical dyssynchrony (MD) parameters in narrow QRS patients
have shown a negative response to CRT. We hypothesized MD in these patients may relate to myocardial scar
rather than electrical dyssynchrony.
Methods:We determined the prevalence of cardiac magnetic resonance (CMR) derived measures of MD in 130
systolic heart failure patients with both broad (≥130 ms - BQRS) and narrow QRS duration (b130 ms - NQRS).
Weassessedwhether late gadoliniumenhancement derived scarmight explain thepresence ofMDamongst nar-
row QRS patients. Dyssynchrony was calculated on the basis of a systolic dyssynchrony index (SDI).
Results: Fifty-nine patients (45%) had a NQRS and the remaining had QRS ≥130 ms (BQRS group). 25% of NQRS
patients had MD based on SDI. In all narrow and broad QRS patients with MD there was a signiﬁcantly lower
scar volume than those without MD (7.4 ± 10.5% vs 13.7 ± 13.3% vs. p b 0.01). This was the case in the BQRS
groupwith a signiﬁcantly lower scar burden in patients with MD (5.0± 7.7% vs 15.4± 15.6%, p b 0.01). Notably
in the NQRS group this difference was absent with an equal scar burden in patients with MD 13.3 ± 13.9% and
without MD 12.5 ± 11%, p = 0.92.
Conclusions: 25% of patients with systolic heart failure and a NQRS (b130 ms) have CMR derived mechanical
dyssynchrony. Our ﬁndings suggest MD in this groupmay be secondary tomyocardial scar rather than electrical
dyssynchrony and therefore not amenable to correction by CRT. Thismay give insight into non-response and po-
tential harm from CRT in this group.





Cardiac magnetic resonance imaging1. Introduction
Cardiac resynchronization therapy (CRT) is a an effective treatment
for patients with systolic heart failure and a broad QRS duration, how-
evermost heart failure patients have narrowQRS [1]. If CRT could be ap-
plied successfully to a proportion of these patients the population
effects would be very large. Imaging derived mechanical dyssynchrony
(MD) parameters have been excluded from recent CRT guidelines [2]
due to their poor performance and reproducibility in the PROSPECT
study [3]. The assessment of mechanical dyssynchrony amongstability and freedom from bias of
epartment, 4th Floor Lambeth
om.
.
lsevier Ireland Ltd. This is an open acpatients with narrow QRS has demonstrated its signiﬁcant prevalence
[4–6], however the RethinQ [7], Lesser-Earth [8] and Echo CRT [9] stud-
ies demonstrated poor response and potential harm in narrow QRS
patients with echocardiographic MD receiving CRT. The mechanisms
underpinning MD in narrow QRS patients and whether such
dyssynchrony is amenable to the electrical treatment of CRT remain un-
clear [10]. Cardiacmagnetic resonance (CMR) is not hindered by acous-
tic windows and offers superior endocardial deﬁnition to assess
volumes andmotion [11]. CMR is the imagingmodality of choice for tis-
sue characterization of myocardial scar with late gadolinium enhance-
ment (LGE) [12]. We have shown that CMR derived dyssynchrony
measures (standard deviation of time to reach minimal volume for
each LV segment; CMR-SDI) are highly reproducible and predicts volu-
metric response to CRT in patients with prolonged QRS [13]. We hy-
pothesized that MD in heart failure patients with narrow QRS may be
due to the presence of myocardial scar rather than as a consequence
of electrical dyssynchrony. This would explain why CRT may not becess article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
82 T. Jackson et al. / IJC Heart & Vasculature 18 (2018) 81–85corrective in such cases. To assess this we determined the prevalence of
CMRderivedmeasures ofMD in systolic heart failure patients with both
broad (≥130 ms) and narrow QRS duration (b130 ms). We further
assessed whether the presence of LGE-derived left ventricular scar
(not amenable to CRT) might explain the presence of mechanical
dyssynchrony amongst narrow QRS patients.
2. Methods
2.1. Inclusion criteria
The local ethics authority approved the study and all patients pro-
videdwritten informed consent; the study complies with the 1975Dec-
laration of Helsinki. Consecutive patients with NYHA II–IV symptomatic
heart failure and an LV ejection fraction (EF) b 35%whowere under the
care of a dedicated heart failure clinic were included regardless of the
QRS duration ormorphology. Patientswere categorized as broad or nar-
row QRS based on a QRS duration b130 ms (NQRS) or ≥130 ms (BQRS)
on the basis of the RethinQ and Echo-CRT studies [7,9].
2.2. MRI assessment of dyssynchrony and myocardial scar
All subjects underwent a CMR scan using either a 1.5T or a 3T MR-
scanner with a 32-element cardiac coil (Achieva, Philips Healthcare,
Best, Netherlands). Steady-state free precession (SSFP) imaging was
performed to generate a short-axis stack of the entire LV and 2-, 3-
and 4-chamber long-axis views of the LV.
2.3. Scar assessment
Delayed contrast-enhanced scar imagingwas performed 15–20 min
following the administration of 0.1–0.2 mmol/kg gadopentetate
dimeglumine (Magnevist®, Bayer Healthcare, Dublin, Ireland) using
conventional inversion recovery techniques. An ischemic etiology was
deﬁned as presence of sub-endocardial scar in two or greater segments.
Scar volumewas calculated using CMR42 (Circle Cardiovascular Imaging
Inc., Calgary, Canada) from the CMR scar imaging short axis stack by
segmenting the endocardial and epicardial borders and applying a
user deﬁned high signal ﬁlter in order to highlight scarred regions;
this was calculated as percentage of total myocardial mass.
2.4. Dyssynchrony assessment
The regional volume change within the LV cavity over the cardiac
cycle for 16 segments (deﬁned using the American Heart Association
model of the LV) was determined using TomTec 4D LV-Analysis soft-
ware (TomTec Imaging systems; Unterschleissheim, Germany). The
software performs semi-automatic segmentation and propagation of
the LV endocardial border from the SA stack and three long axis SSFP
cine images [13,14]. The CMR-SDIwas calculated for regional cavity vol-
ume change and deﬁned as the standard deviation (SD) of the regionalTable 1
Baseline characteristics, scar volume and CMR-SDI for all patients. Values are mean ± SD or n
All
(n = 130)
Age 64.7 ± 13.8
Sex M 106 (81)
F 24 (19)
Ejection fraction (%) 26.8 ± 8.6
QRSd (ms) 137 ± 30
QRS morphology LBBB 75 (58)
RBBB 2 (2)
NIVCD 5 (4)
Etiology NI 70 (54)
I 60 (46)times to peak volume change for the 16 segments. The CMR-SDI was
expressed as a percentage of the cardiac cycle to allow for heart rate var-
iation. An SDI of ≥9.75%was used as a deﬁnition of presence of mechan-
ical dyssynchrony [13].2.5. Statistics
Statistical analysis was performed on PASW Statistics 21 (SPSS Inc.,
Chicago, IL, USA). The Shapiro-Wilk test was used to ensure variables
were normally distributed. Continuous variables were expressed as
mean ± SD. Group comparisons were performed using an independent-
samples t-test for normally distributed data, and the Mann-Whitney U
test if deemed non-parametric. Nominal variables were expressed as ab-
solute count and percentages and compared with a Chi-squared test or a
Fisher's exact test dependent on number. Relationships were assessed
using the Pearson correlation coefﬁcient. Values of p b 0.05 were consid-
ered statistically signiﬁcant.3. Results
3.1. Baseline characteristics (see Table 1)
A total of 130 patients underwent CMR assessment of mechanical
dyssynchrony. Mean age was 64.7 ± 13.8 and 106 (81%) were men.
Sixty patients (46%) had an ischemic cardiomyopathy; late gadolinium
enhancement imaging was precluded in 6 patients due to renal func-
tion. Mean CMR derived EF was 26.8 ± 8.6% and mean QRS duration
was 137 ± 30 ms. A left bundle branch block morphology (LBBB) was
present in 75 (58%) patients, right bundle branch block (RBBB) in
2 (2%), non-speciﬁc intraventricular conduction delay (NIVCD) in
5 (4%) and 48 (36%) had no conduction delay. When dichotomizing
the cohort by QRS duration 71 patients had a QRS duration ≥130 ms
(BQRS group) and 59 had a QRS duration b130 ms (NQRS group). Pa-
tients with NQRS were younger (61.7 ± 14.7 yrs. vs. 67.2 ± 12.5 yrs.,
p = 0.03). The mean QRS duration in the NQRS group was 109 ±
11ms and in the BQRS group 160± 20ms (p b 0.01). Six of 59 patients
(10%) of the NQRS group fulﬁlled (non-strict) criteria for LBBB com-
pared to 69/71 (97%) in the BQRS group (p b 0.01) (Table 1).
The mean scar volume for the entire cohort was 11.0 ± 5.6%.3.2. Mechanical dyssynchrony
The mean CMR-SDI was 10.6 ± 5.6% with signiﬁcant difference
between those with NQRS and BQRS (8.9 ± 5.2% vs. 12.1 ± 5.7%,
p b 0.01, Fig. 1). On the basis of our pre-speciﬁed cut off of
SDI ≥9.75% MD was present in 25% of NQRS patients and 56% of broad
QRS patients. (χ2= 12.62, p b 0.01). Therewas amodest correlation be-







61.7 ± 14.7 67.2 ± 12.5 p = 0.03
46 (78) 60 (84) χ2 = 0.92
p = 0.3413 (22) 11 (16)
28.2 ± 9.1 25.6 ± 8.0 p = 0.09
109 ± 11 160 ± 20 p b 0.01
6 (10) 69 (97) p b 0.01
0 (0) 2 (3)
5 (8) 0(0)
29 (49) 41 (58) χ2 = 0.96
p = 0.3330 (51) 30 (42)
Fig. 1. A) Box plot of CMR-SDI (SDI 16%) for patients with a QRS b 130 ms and QRS
≥ 130 ms. Grey horizontal line represents mean for entire cohort. B) Scatter diagram of
QRS duration (ms) and Systolic CMR-SDI (SDI 16%). with regression line of best ﬁt and
95% conﬁdence intervals (dashed lines); R = 0.38, p b 0.01.
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Ejection fraction (EF) was not signiﬁcantly different between
ischemic and non-ischemic patients. Ischemic patients had narrower
QRS durations (131 ± 26 vs. 142 ± 33 ms, p = 0.04) and a lowerFig. 2. Scatter diagrams of left ventricular scar volume (%age scar) plotted against CMR-SDI (SDI 1CMR-SDI (9.4 ± 4.4 vs. 11.6 ± 6.4%, p = 0.03); in keeping with this,
patients with CMR deﬁned scar had shorter QRS durations (127 ± 24
vs. 148 ± 34 ms, p b 0.01) and a lower SDI (9.4 ± 4.8 vs. 12.1 ± 6.3%,
p b 0.01) without different EFs. There was a signiﬁcant negative
correlation between scar burden and both QRS duration and SDI (R =
−0.23, p = 0.01 & R =−0.21, p = 0.02 respectively) (Fig. 2).
3.4. Relationship between dyssynchrony and scar
Scar volume was compared in patients on the basis of presence or
absence of MD. In the whole cohort (incorporating NQRS and BQRS),
those patients with mechanical dyssynchrony had a signiﬁcantly
lower scar volume (7.4 ± 10.5% vs 13.7 ± 13.3% vs. p b 0.01). This
was the case in the BQRS group with a signiﬁcantly lower scar burden
in patients with MD (5.0 ± 7.7% vs 15.4 ± 15.6%, p b 0.01). Notably in
the NQRS group this difference was absent with an equal scar burden
in patients with MD 13.3 ± 13.9% and without MD 12.5 ± 11%, p =
0.92 (Fig. 3). These analyses were repeated for non-ischemic and ische-
mic patients; in non-ischemic patients there was less scar in the BQRS
group (1.4 ± 6.8 vs. 3.5 ± 5.9%, p = 0.01) but no difference in amount
of scar when analysed for those with and without MD in each group. In
ischemic patients therewas nodifference in scar volumebetweenNQRS
and BQRS (21.3±9.8 vs. 22.9±8.4%, p=0.52), however therewas less
scar in the BQRS MD patients than those without MD (16.8 ± 3.1 vs.
27.0 ± 8.4%, p b 0.01), this was not the case in the NQRS patients
(24.8 ± 12.4 vs. 20.4 ± 9.0%, p = 0.37) (see Supplementary Table 1).
Analysis of all patients with MD showed more scar in the NQRS group
than in the BQRS group. (13.3 ± 13.9% vs. 5.0 ± 7.7%, p b 0.01).
4. Discussion
Our study represents one of the largest experiences of CMR derived
indices of MD in heart failure patients.
The main ﬁndings of the current study are that:
1. CMR derivedMDwas present in 25% of systolic heart failure patients
with a narrow QRS (b130 ms).
2. Patients with a broad QRS duration (N130 ms) and MD had signiﬁ-
cantly lower scar burden than those without MD.
3. NarrowQRS patients withMDhad an equal scar burden compared to
those without MD.
4. Broad QRS patients with MD had a signiﬁcantly lower scar burden
than narrow QRS patients with MD.
4.1. Prevalence of mechanical dyssynchrony
This study demonstrates that even amongst heart failure patients
with a narrow QRS (b130 ms) there is a signiﬁcant amount of CMR6%) inA andQRS duration inB. Patientswith no scar are representedwith greydatapoints.
Fig. 3. Box plots of left ventricular scar volume (Scar %) for those patientswith andwithout
mechanical dyssynchrony (MD). Plot A is all patients, B is narrow QRS patients (QRS
b 130 ms), and C is Broad QRS patients (QRS ≥ 130 ms).
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quarter of patients with narrow QRS represents approximately 15% of
all heart failure patients [1]. This rate of MD is lower than seen in previ-
ous echocardiographic based studies [4,15,16]. We believe this CMR
technique to bemore representative of truemotion, due to better endo-
cardial tracking, and may therefore CMR derived MD may be more re-
producible than echocardiographic measures and more representative
of the true incidence of MD in patients with narrow QRS [13].
4.2. Scar and mechanical dyssynchrony
The presence of scar is a signiﬁcant confounder in the association be-
tween QRS duration and dyssynchrony. In the whole cohort, patients
with a narrow QRS had more scar than those with a broad QRS. We
found a signiﬁcant negative correlation between scar volume andMRI-SDI driven by those patients without scar having a greater MRI-
SDI. 97% of patients with broad QRS duration in our study had left bun-
dle branch block (LBBB)whereas only 10% of the narrowQRS group had
LBBB.
Those patientwith QRSb130ms could have non-speciﬁc conduction
delay secondary to fractionated QRS complexes due to scar supported
by the distribution of QRS morphologies between groups as well as
the signal for greater scar volumes amongst patients with shorter QRS
durations.
For patients with narrow QRS and an ischemic etiology it has previ-
ously been supposed that the presence of mechanical dyssynchrony is a
consequence of areas of scar leading to regional variability in contractil-
ity [15,17].
4.3. Mechanisms of dyssynchrony in narrow and broad QRS and potential
importance to CRT response
Our data would be in keeping with the hypothesis that in patients
with broad QRS, which is predominantly LBBB, that the mechanical
dyssynchrony seen in this patient group is secondary to the electrical
dyssynchronydue to the primary electrical disturbance; i.e. there is cou-
pling of excitation and contraction. As theMD is due to the electrical ab-
normality then this would be amenable to correction with CRT. Our
ﬁndings are in support of this as CRT is an efﬁcacious treatment in
such patients with LBBB. Conversely in the narrow QRS group our hy-
pothesis that mechanical dyssynchrony is caused by myocardial scar is
supported by our ﬁndings. Despite the prevalence of MD in a quarter
of the NQRS patients we studied this was associated with a large scar
burden. Left ventricular scar has an adverse effect on CRT response in
terms of acute hemodynamic measures [18], chronic remodeling [19],
and clinical improvement or mortality [20,21]. CRT outcomes are ad-
versely affected by total scar volume and the location of scar at the
site of the LV lead [12,22]. We have demonstrated that narrow QRS pa-
tients can have mechanical dyssynchrony, however these patients also
have left ventricular scar diminishing their ability to respond. The pres-
ence of dyssynchrony in the narrow QRS group is likely to be related to
scar rather than electrical dyssynchrony and is therefore a substrate not
amenable to CRT as there is no correctable electrical delay in these pa-
tients, which remains the primary target for CRT treatment. Ourﬁndings
ofMD in narrowQRS patients being caused by scar rather than electrical
delay may also provide an insight into the potential for harm from CRT
in this patient group as pacing in or adjacent to areas of scar have thepo-
tential result in adverse electrophysiological changeswhichmay predis-
pose to reentrant ventricular arrhythmias [23].
Other potential mechanisms to explain the MD seen in our narrow
QRS patients include regional variability in multiple cell and molecular
pathways including calcium handling proteins, cardiotrophin-1,
connexin 43, stress-response kinases and tissue necrosis factor expres-
sion [24–26]. CMR derived T1mapping gives an insight into the amount
of myocardial free water in both the extra cellular volume and the cells
and therefore elevated levels represent edema or protein deposition
seen in preclinical ﬁbrotic changes [27]. Further investigation with this
new technique may indicate whether the pathways involved are likely
to be those that modify myocardial architecture or those involved in
contractility modulation (i.e. calcium handling proteins as opposed to
stress-response kinases).
4.4. Limitations
Wehave described one of the largestMRI studies of dyssynchrony in
heart failure patients with the particular interest in assessing the pres-
ence and etiology of MD amongst narrow QRS patients. This said the
number of narrow QRS patients is relatively small andmay not truly re-
ﬂect the whole population, although this is one of the largest cohorts
published in this area. We have not progressed to assess the impact of
CMR-SDI deﬁned mechanical dyssynchrony amongst narrow QRS
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the publication of Echo-CRTwe should be cautious in these studies until
we know more about potential treatable mechanisms for mechanical
dyssynchrony. One important consideration with respect to the preva-
lence of mechanical dyssynchrony is that by nature of the fact that the
regional volume changes are reduced in systolic heart failure, the mea-
surement of peak volume change is far more difﬁcult because of these
lower amplitude permutations. One criticism of the use of CMR as op-
posed to 2-dimensional echocardiography for SDI is that the temporal
resolution is lower which may amplify this difﬁculty. Although this ar-
gument is technically sound, our group has previously shown that in
predicting CRT response this CMR-SDI technique outperforms echocar-
diographic markers of dyssynchrony [13], thereforewe feel the beneﬁts
it brings in spatial resolution and image clarity more than compensates
for this issue. The majority of the BQRS patients were LBBB patients,
meaning that right bundle branch block and nonspeciﬁc intraventricu-
lar conduction delay patients may be under-represented; this may in-
troduce some bias into the dataset. Further work is needed to consider
whether other mechanisms such as cellular contractility modulation
or electrical remodeling are at play, and ultimately whether these
mechanisms are amenable to treatment with CRT which could beneﬁt
this signiﬁcant number of heart failure patients.
4.5. Conclusions
A quarter of patients with systolic heart failure and a narrow QRS
(b130 ms) have CMR derived mechanical dyssynchrony. Our ﬁndings
suggest that MD in this group is secondary to myocardial scar rather
than electrical dyssynchrony and therefore not amenable to correction
by CRT. Our ﬁndings may give insight into the reason for non-
response and potential harm from CRT in this patient group.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ijcha.2017.11.005.
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